News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,417 Results
Type
Article (39560)
Company Profile (247)
Press Release (656610)
Section
Business (204113)
Career Advice (2007)
Deals (35417)
Drug Delivery (94)
Drug Development (81013)
Employer Resources (172)
FDA (16157)
Job Trends (14844)
News (345067)
Policy (32501)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2547)
Accelerated approval (4)
Adcomms (20)
Allergies (80)
Alliances (49380)
ALS (83)
Alzheimer's disease (1357)
Antibody-drug conjugate (ADC) (109)
Approvals (16159)
Artificial intelligence (233)
Autoimmune disease (16)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (175)
Bladder cancer (58)
Brain cancer (25)
Breast cancer (252)
Cancer (2017)
Cardiovascular disease (162)
Career advice (1674)
Career pathing (29)
CAR-T (140)
Cell therapy (397)
Cervical cancer (19)
Clinical research (65742)
Collaboration (769)
Compensation (466)
Complete response letters (19)
COVID-19 (2581)
CRISPR (35)
C-suite (211)
Cystic fibrosis (98)
Data (1987)
Decentralized trials (2)
Denatured (16)
Depression (38)
Diabetes (249)
Diagnostics (6337)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (113)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (86223)
Editorial (32)
Employer branding (21)
Employer resources (146)
Events (111719)
Executive appointments (649)
FDA (17279)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (691)
Gene editing (97)
Generative AI (18)
Gene therapy (278)
GLP-1 (685)
Government (4383)
Grass and pollen (4)
Guidances (49)
Healthcare (18811)
Huntington's disease (22)
IgA nephropathy (24)
Immunology and inflammation (103)
Indications (26)
Infectious disease (2713)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (87)
Interviews (311)
IPO (16489)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (34)
Layoffs (455)
Leadership (16)
Legal (7901)
Liver cancer (70)
Lung cancer (293)
Lymphoma (134)
Machine learning (4)
Management (58)
Manufacturing (268)
MASH (61)
Medical device (13326)
Medtech (13331)
Mergers & acquisitions (19409)
Metabolic disorders (632)
Multiple sclerosis (72)
NASH (16)
Neurodegenerative disease (80)
Neuropsychiatric disorders (24)
Neuroscience (1841)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2458)
Now hiring (37)
Obesity (340)
Opinion (201)
Ovarian cancer (72)
Pain (78)
Pancreatic cancer (76)
Parkinson's disease (138)
Partnered (20)
Patents (204)
Patient recruitment (97)
Peanut (46)
People (57106)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20473)
Phase II (28948)
Phase III (21580)
Pipeline (1058)
Podcasts (45)
Policy (114)
Postmarket research (2563)
Preclinical (8659)
Press Release (64)
Prostate cancer (94)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (359)
Real estate (5901)
Recruiting (65)
Regulatory (22155)
Reports (46)
Research institute (2318)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (64)
Series A (121)
Series B (78)
Service/supplier (11)
Sickle cell disease (51)
Southern California (2118)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3572)
State (2)
Stomach cancer (13)
Supply chain (60)
Tariffs (11)
The Weekly (27)
United States (21328)
Vaccines (657)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (16)
Last 7 days (653)
Last 30 days (2537)
Last 365 days (33375)
2025 (8276)
2024 (35220)
2023 (40076)
2022 (51173)
2021 (55714)
2020 (54086)
2019 (46539)
2018 (35020)
2017 (32110)
2016 (31488)
2015 (37557)
2014 (31320)
2013 (26349)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (718)
Alabama (49)
Alaska (7)
Arizona (224)
Arkansas (13)
Asia (37724)
Australia (6170)
California (5582)
Canada (1880)
China (476)
Colorado (247)
Connecticut (256)
Delaware (128)
Europe (80880)
Florida (828)
Georgia (196)
Idaho (57)
Illinois (500)
India (24)
Indiana (292)
Iowa (9)
Japan (143)
Kansas (101)
Kentucky (23)
Louisiana (9)
Maine (61)
Maryland (834)
Massachusetts (4195)
Michigan (209)
Minnesota (371)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1592)
New Mexico (28)
New York (1603)
North Carolina (922)
North Dakota (7)
Northern California (2458)
Ohio (192)
Oklahoma (14)
Oregon (33)
Pennsylvania (1264)
Puerto Rico (9)
Rhode Island (27)
South America (1095)
South Carolina (18)
South Dakota (1)
Southern California (2118)
Tennessee (95)
Texas (832)
Utah (164)
Virginia (130)
Washington D.C. (57)
Washington State (516)
West Virginia (3)
Wisconsin (49)
696,417 Results for "eddingpharm cayman inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com
Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com.
June 6, 2024
·
2 min read
Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies
Cayman Chemical, a leading supplier of research tools for lipid nanoparticles (LNPs), announced today the introduction of LipidLaunch™ research-ready LNPs and reagent kits.
February 20, 2024
·
2 min read
Press Releases
Cayman and Certest Announce Partnership, Expanding Access to Ionizable Lipids for Lipid Nanoparticles
August 21, 2024
·
3 min read
Cayman Chemical Receives CEP for Latanoprost API from EDQM
Cayman Chemical, a world leader in the manufacture of prostaglandins for both research use and as active pharmaceutical ingredients
September 19, 2023
·
1 min read
News
Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR)
July 8, 2024
·
9 min read
Cayman and Navinci Announce Strategic Partnership, Expanding Access to Next-Generation Tools for Spatial Proteomics
Global life sciences supplier Cayman Chemical (Cayman) announced today a strategic partnership with Navinci Diagnostics (Navinci), a Swedish biotechnology company developing innovative tools for spatial proteomics.
July 11, 2023
·
4 min read
Policy
Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China
Amarin Corporation plc announced that its commercial partner in China, EddingPharm, has received regulatory approval for VASCEPA® from China’s National Medical Products Administration.
June 1, 2023
·
9 min read
China Jo-Jo Drugstores, Inc. Announces 1-for-20 Reverse Stock Split
China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company, reported that it expects to implement a 1-for-20 reverse stock split on its ordinary shares effective Friday, March 1, 2024, with trading to begin on a split-adjusted basis at the market open on that day.
February 27, 2024
·
3 min read
Press Releases
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
April 3, 2025
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
March 20, 2025
·
4 min read
1 of 69,642
Next
